KHSRP: A Potential Drug Target and Biomarker for Cancer (G8570)

Target Name: KHSRP

NCBI ID: G8570

KHSRP

KHSRP: A Potential Drug Target and Biomarker for Cancer

Khurshidine (KHSRP) is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and kidneys. It is a member of the FUSE (fused in situ hybridization) binding protein family, which is a family of transmembrane proteins that play a crucial role in various cellular processes. KHSRP is known to interact with several other proteins, including the transcription factor p53, and it has been shown to be involved in various cellular processes, including cell growth, apoptosis, and inflammation.

Drug Targeting

KHSRP has been identified as a potential drug target due to its involvement in various cellular processes that are crucial for human health. One of the main reasons for its potential as a drug target is its involvement in cell apoptosis, which is a natural process that helps the body eliminate damaged or dysfunctional cells.

KHSRP has been shown to play a role in regulating apoptosis, specifically in the regulation of programmed cell death (programmed cell death) or apoptosis. This is evident from studies that have shown that KHSRP can induce apoptosis in various cell types, including cancer cells , and that it can also induce apoptosis in the brain, which is a critical organ that is responsible for the maintenance of the body's cellular homeostasis.

Another potential drug target for KHSRP is its role in cell proliferation. KHSRP has been shown to play a role in regulating cell proliferation, and it has been shown to inhibit the growth of various cancer cells. This is important because cancer is a leading cause of death in the world, and targeting KHSRP as a drug target could lead to the development of new treatments for this deadly disease.

Biomarker

In addition to its potential as a drug target, KHSRP has also been identified as a potential biomarker for various diseases, including cancer. This is because KHSRP is expressed in various tissues of the body and can be used as a marker for the presence of cancer. cells.

Studies have shown that KHSRP is expressed in various types of cancer, including breast, lung, and ovarian cancer. This suggests that KHSRP could be used as a potential biomarker for these types of cancer. Additionally, KHSRP has been shown to be involved in the regulation of cell apoptosis, which is a crucial process that is involved in the regulation of cancer cell growth and progression. This suggests that KHSRP could be used as a potential biomarker for the progression of cancer.

Conclusion

KHSRP is a protein that has been shown to interact with several other proteins and to play a role in various cellular processes. Its potential as a drug target and biomarker make it an important target for research into the mechanisms of cancer and other diseases. Further studies are needed to fully understand the role of KHSRP in these processes and to develop new treatments for cancer and other diseases.

Protein Name: KH-type Splicing Regulatory Protein

Functions: Binds to the dendritic targeting element and may play a role in mRNA trafficking (By similarity). Part of a ternary complex that binds to the downstream control sequence (DCS) of the pre-mRNA. Mediates exon inclusion in transcripts that are subject to tissue-specific alternative splicing. May interact with single-stranded DNA from the far-upstream element (FUSE). May activate gene expression. Also involved in degradation of inherently unstable mRNAs that contain AU-rich elements (AREs) in their 3'-UTR, possibly by recruiting degradation machinery to ARE-containing mRNAs

The "KHSRP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KHSRP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets